George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMYSL.L Regulatory News (MYSL)

  • There is currently no data for MYSL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) MySale Group PLC

5 Jul 2019 17:00

RNS Number : 7015E
MySale Group PLC
05 July 2019
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

MySale Group plc ("MySale")

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

MySale

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

5 July 2019

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary shares of 10 pence each

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

Nil

Nil

Nil

(2) Cash-settled derivatives:

 

Nil

Nil

Nil

Nil

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

Nil

Nil

Nil

 

TOTAL:

Nil

Nil

Nil

Nil

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

NONE

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

The directors of MySale have the following interests in MySale:

 

Name

No. of ordinary shares held

% of ordinary issued share capital

Jamie Jackson

47,469,189

31.4%

Carl Jackson

3,745,000

2.5%

Charles Butler

17,000

0.0%

David Mortimer AO

165,000

0.1%

 

The directors of the Company have the following rights to subscribe for the following relevant MySale securities:

 

Name

Plan

Date of grant

Options price (pence)

No. of options outstanding

Carl Jackson

Loan Share Plan

14 June 2014

2.26

111,499

 

The Company's employee benefit trust ("EBT"), of which MySale Group Trustee Limited (the "Trustee") is trustee, holds 3,000,000 ordinary shares in the Company. Carl Jackson and Jamie Jackson are the directors of the Trustee. Ordinary shares held by the EBT are unable to be voted, in line with the EBT's rules.

 

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

5 July 2019

Contact name:

CARL JACKSON

Telephone number:

+61(02)91198950

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FEEEELFBKDFEBBZ
Date   Source Headline
15th Jun 20214:36 pmRNSPrice Monitoring Extension
4th Jun 20214:41 pmRNSSecond Price Monitoring Extn
4th Jun 20214:36 pmRNSPrice Monitoring Extension
24th May 20214:40 pmRNSSecond Price Monitoring Extn
24th May 20214:35 pmRNSPrice Monitoring Extension
12th May 20214:40 pmRNSSecond Price Monitoring Extn
12th May 20214:35 pmRNSPrice Monitoring Extension
30th Mar 20217:00 amRNSHalf Year Results
22nd Feb 20214:40 pmRNSSecond Price Monitoring Extn
22nd Feb 20214:35 pmRNSPrice Monitoring Extension
22nd Jan 20217:00 amRNSHalf Year Trading Update
12th Jan 20214:41 pmRNSSecond Price Monitoring Extn
12th Jan 20214:35 pmRNSPrice Monitoring Extension
21st Dec 20207:00 amRNSResult of AGM
17th Dec 20204:41 pmRNSSecond Price Monitoring Extn
17th Dec 20204:36 pmRNSPrice Monitoring Extension
16th Dec 20204:41 pmRNSSecond Price Monitoring Extn
16th Dec 20204:36 pmRNSPrice Monitoring Extension
26th Nov 20207:00 amRNSFinal Results
29th Oct 20204:41 pmRNSSecond Price Monitoring Extn
29th Oct 20204:35 pmRNSPrice Monitoring Extension
23rd Oct 20204:41 pmRNSSecond Price Monitoring Extn
23rd Oct 20204:35 pmRNSPrice Monitoring Extension
16th Oct 20206:25 pmRNSHolding(s) in Company
16th Oct 20206:25 pmRNSHolding(s) in Company
12th Oct 20207:00 amRNSManagement Incentive Scheme and Issue of Equity
9th Oct 20202:00 pmRNSManagement Incentive Scheme and Issue of Equity
9th Oct 20202:00 pmRNSHolding(s) in Company
8th Oct 20207:00 amRNSSubscription for approximately £5.1 million
6th Oct 20201:52 pmRNSHolding(s) in Company
17th Sep 202012:08 pmRNSSecond Price Monitoring Extn
17th Sep 202012:02 pmRNSPrice Monitoring Extension
19th Aug 20204:40 pmRNSSecond Price Monitoring Extn
19th Aug 20204:35 pmRNSPrice Monitoring Extension
3rd Aug 20208:42 amRNSManagement Incentive Scheme and Issue of Equity
29th Jul 20207:00 amRNSTrading Update
26th Jun 20209:20 amRNSHolding(s) in Company
17th Jun 20204:41 pmRNSSecond Price Monitoring Extn
17th Jun 20204:36 pmRNSPrice Monitoring Extension
2nd Jun 202010:20 amRNSHolding(s) in Company
29th Apr 202012:31 pmRNSManagement Incentive Scheme and Issue of Equity
1st Apr 20207:10 amRNSHalf Year Results
1st Apr 20207:00 amRNSAppointment of Joint Broker
30th Mar 20207:00 amRNSHolding(s) in Company
25th Mar 20204:42 pmRNSSecond Price Monitoring Extn
25th Mar 20204:36 pmRNSPrice Monitoring Extension
9th Mar 20207:00 amRNSAppointment of CFO
4th Feb 20209:05 amRNSHolding(s) in Company
27th Jan 20207:00 amRNSDirector/PDMR Shareholding
16th Jan 20207:00 amRNSPre-close Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.